Table 4: Factors associated with the clinical outcome.

VariableTreatment outcomeCrude OR 95% CIAdjusted OR 95% CI
Improved (125; 57.6%)Unimproved (92; 42.4%)

Sex
 Male83 (38.25)39 (17.97)11
 Female42 (19.35)53 (24.42)2.686 1.541–4.6812.919 1.527–5.279
Residence
 Urban74 (34.01)51 (23.51)11
 Rural51 (23.50)41 (18.89)1.166 0.677–2.0100.812 0.380–1.734
Disease duration
 Less than two years41 (18.89)51 (23.50)11
 More than two years84 (15.47)41 (18.89)0.392 0.225–1.6840.249 0.122–1.508
Distance
 <2 hours94 (43.32)59 (27.19)11
 ≥2 hours31 (14.29)33 (15.21)1.333 0.49–2.6861.367 0.603–3.099
Other psychiatric illnesses
 Yes68 (43.31)57 (26.26)11
 No57 (26.26)35 (16.13)1.365 0.789–2.3630.824 0.414–1.642
Naranjo score
 Possible10 (4.60)9 (4.15)1Ref
 Probable91 (41.93)77 (35.48)0.940 0.363–2.4320.898 0.303–2.669
Level of adherence
 Optimal62 (28.57)31 (14.28)0.37 0.110–5.3790.432 0.201–0.909
 Suboptimal63 (29.03)61 (28.11)11
Severity of ADR
 Moderate86 (39.63)64 (29.49)11
 Sever14 (6.45)22 (10.14)2.112 1.003–4.4442.133 0.912–4.990

Statistically significant at 0.05. Significant at 0.01.